Desin And Development of Immediate Release Tablet Using Kollidon 90f As Carrier

The aim of the present study is desin and development of immediate release tablet using kollidon 90f as carrier. For immediate release of drugs from tablets, the superdisintegrants sodium strach glycolate (SSG), crospovidone (CP), and croscarmellose sodium (CCS) were employed. Every pre-compression and post-compression parameter was assessed for the manufactured tablets. By using FTIR, the drug-excipient interaction was examined. Every formulation demonstrated adherence to pharmacopoeial guidelines. According to the study, glipizide formulations generated by direct compression F6 demonstrate the maximum dissolution utilizing crospovidone and faster drug release, 92.74% over a 60-minute period

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-31
DOI
https://doi.org/10.5281/zenodo.14580674
Primary Topic
Cardiac electrophysiology and arrhythmias
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Desin And Development of Immediate Release Tablet Using Kollidon 90f As Carrier

Zenodo (CERN European Organization for Nuclear Research)
Cardiac electrophysiology and arrhythmias
article

Desin And Development of Immediate Release Tablet Using Kollidon 90f As Carrier

article en

Abstract

The aim of the present study is desin and development of immediate release tablet using kollidon 90f as carrier. For immediate release of drugs from tablets, the superdisintegrants sodium strach glycolate (SSG), crospovidone (CP), and croscarmellose sodium (CCS) were employed. Every pre-compression and post-compression parameter was assessed for the manufactured tablets. By using FTIR, the drug-excipient interaction was examined. Every formulation demonstrated adherence to pharmacopoeial guidelines. According to the study, glipizide formulations generated by direct compression F6 demonstrate the maximum dissolution utilizing crospovidone and faster drug release, 92.74% over a 60-minute period

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 47%
Cardiac electrophysiology and arrhythmias
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Desin And Development of Immediate Release Tablet Using Kollidon 90f As Carrier · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS